International Isotopes Inc is primarily active in the industries of nuclear medicine, radiopharmaceuticals, and nuclear energy.

The main competitors of International Isotopes Inc in the market include companies such as Lantheus Holdings Inc, GE Healthcare, Cardinal Health, and Bracco Imaging.

International Isotopes Inc (INIS) is a renowned company focused on the production and sale of nuclear medicine products. Established in 1995, INIS has become a prominent player in the global market. The company excels in providing a wide range of products and services, including radiological and nuclear materials, cobalt teletherapy sources, and calibration and reference sources. INIS has built a solid reputation through its commitment to quality, safety, and reliability. With their state-of-the-art facilities and expertise, International Isotopes Inc continues to be a leading provider of innovative solutions in the nuclear medicine industry.

International Isotopes Inc has achieved several significant milestones in its history. One of the major achievements includes the completion of its technetium-99m production facility in 2017, which positioned the company as a reliable supplier of medical isotopes. Additionally, the company successfully obtained a Drug Master File from the U.S. Food and Drug Administration for its radiopharmaceutical product, Sodium Iodide I-131, a crucial step in expanding its product offerings. Furthermore, International Isotopes Inc has made notable advancements in its proprietary processes for recycling used nuclear fuel, contributing to the development of a more sustainable and environmentally friendly nuclear industry.

International Isotopes Inc is primarily present in the United States.

International Isotopes Inc is a company that values integrity, innovation, and excellence in providing reliable and high-quality isotopes for various industries. With a strong corporate philosophy, International Isotopes Inc is committed to meeting the specific needs of its customers by offering a diverse range of products and services. The company strives to maintain strong relationships with its clients by consistently delivering exceptional value and ensuring customer satisfaction. International Isotopes Inc remains dedicated to continuous improvement and growth, fostering a culture of collaboration and efficiency. Through their dedication to advancing technology and emphasizing ethical conduct, International Isotopes Inc has established itself as a trusted leader in the industry.

Converted at the current exchange rate, the RADNOSTIX, INC. share trades at 0,06 EUR (0,07 USD).

International Isotopes Inc is a company that specializes in the production and marketing of radioactive and nuclear products. They offer products and services for the preservation, security, and use of isotopes. The company has been active in the market since 1995 and is headquartered in Idaho Falls, USA.

Liikevaihtoa ei voida laskea RADNOSTIX, INC.:lle tällä hetkellä.

Voittoa ei voida laskea RADNOSTIX, INC.:lle tällä hetkellä.

P/E-suhdetta ei voida laskea RADNOSTIX, INC.:lle tällä hetkellä.

P/S-suhdetta ei voida laskea RADNOSTIX, INC.:lle tällä hetkellä.

RADNOSTIX, INC.:n Eulpool-laatuscore on 3/10.

RADNOSTIX, INC.:n ISIN on US45972C1027. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.

RADNOSTIX, INC.:n WKN on 914371. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.

RADNOSTIX, INC.:n ticker on INIS. Tämä pörssinoteeraus käytetään RADNOSTIX, INC.-osakkeiden kauppaan pörssissä.

RADNOSTIX, INC. maksoi osinkoa joka vuosi viimeisten 0 vuoden aikana.

RADNOSTIX, INC. kuuluu sektoriin 'Terveydenhuolto'.

RADNOSTIX, INC.:n osingot jaetaan valuutassa USD.